Soil and plant-based ecosystem functions dataset of three land-use types in northwestern Virginia.

Variables that quantify nutrient cycling in terrestrial ecosystems, including aboveground and belowground biomass, litter biomass, inorganic nitrogen (NH and NO ), and soil CO efflux were measured . From measured variables, seasonal litter inputs and nitrogen mineralization were also estimated. Data were collected over the course of one to two growing seasons (2017 and 2018) across three different land-use types under variable human management: an agricultural field (cultivating millet for the duration of the first growing season of the study and left fallow for the duration of the second growing season), a restored native C tallgrass prairie, and an approximately 16-year-old successional field.

Somatic Tumor Profile Analysis in a Patient with Germline Mutation and Synchronous Ovarian and Uterine Carcinomas.

Lynch syndrome patients with synchronous endometrial and ovarian cancer (SEOC) are rare. When these cases occur, they are most often endometrioid histology and early grade. Early-grade tumors are not often sent for somatic tumor profiling.

Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease.

Chronic graft-versus-host disease (cGVHD) continues to be a major complication after allogeneic hematopoietic cell transplantation, significantly affecting patients' quality of life. A regimen of systemic corticosteroids is considered first-line therapy but is often associated with inadequate responses and multiple side effects. In patients with refractory disease, an evidenced-based consensus is lacking as to the single best approach to managing symptoms.

Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing.

Background: This study seeks to determine whether there is a delay in time to surgery in breast cancer patients with panel tests compared with traditional BRCA testing.

Methods: This study was a retrospective review of women diagnosed with breast cancer who underwent genetic evaluation from our institution's Genetic Counselor Database from January 2013 to August 2015. Patients were excluded if they were male, clinical information was unavailable, the patient underwent neoadjuvant chemotherapy, had a diagnosis of recurrent breast cancer during time of study, or had postoperative genetics evaluation.